Literature DB >> 9225797

Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT.

P Bartenstein1, S Minoshima, C Hirsch, K Buch, F Willoch, D Mösch, D Schad, M Schwaiger, A Kurz.   

Abstract

UNLABELLED: This study evaluated an automated analysis of SPECT brain imaging in patients with Alzheimer's disease (AD).
METHODS: Patients [n = 81; mean age, 69.9 +/- 10.6 yr (mean +/- s.d.)] with a clinical diagnosis of probable AD (NINCDS-Alzheimer's Disease and Related Disorders Association criteria) underwent 99mTc-ethyl cysteine dimer SPECT imaging. After imaging registration and data extraction using three-dimensional stereotactic surface projections, a pixel-wise comparison of ethyl cysteine dimer uptake was performed using a reference database of 10 cognitive intact controls of comparable age.
RESULTS: When individual cases were compared to the normal database, temporo-parietal regional cerebral blood flow (rCBF) abnormalities across different levels of dementia severity were clearly depicted on pixel-wise Z-score images. The rCBF reduction in cortical association areas showed a significant correlation with an overall level of cognitive decline, as assessed by the Mini Mental State Examination and by the cognitive section of the Cambridge Mental Disorders of the Elderly Examination. In addition, there were significant region-specific correlations between left temporo perfusion deficit and language performance and between right parietal rCBF reduction and praxis.
CONCLUSION: These results indicate that this observer-independent analysis of SPECT data enables objective and semiquantitative assessment of the magnitude and extent of cortical perfusion abnormalities in patients with AD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9225797

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  34 in total

1.  Observer independent analysis of cerebral glucose metabolism in patients with chronic fatigue syndrome.

Authors:  T Siessmeier; W A Nix; J Hardt; M Schreckenberger; U T Egle; P Bartenstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

2.  Diagnosis of suspected Alzheimer's disease is improved by automated analysis of regional cerebral blood flow.

Authors:  Bich-Ngoc-Thanh Tang; Satoshi Minoshima; Jean George; Annie Robert; Christian Swine; Patrice Laloux; Thierry Vander Borght
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-01       Impact factor: 9.236

3.  Global cognitive impairment should be taken into account in SPECT-neuropsychology correlations: the example of verbal memory in very mild Alzheimer's disease.

Authors:  G Rodriguez; S Morbelli; A Brugnolo; P Calvini; N Girtler; A Piccardo; N J Dougall; K P Ebmeier; J C Baron; F Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-06-02       Impact factor: 9.236

Review 4.  Interventions for heart disease and their effects on Alzheimer's disease.

Authors:  Benjamin Wolozin; Martin M Bednar
Journal:  Neurol Res       Date:  2006-09       Impact factor: 2.448

Review 5.  Alzheimer's disease and mild cognitive impairment.

Authors:  Brendan J Kelley; Ronald C Petersen
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

6.  EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2.

Authors:  Ozlem L Kapucu; Flavio Nobili; Andrea Varrone; Jan Booij; Thierry Vander Borght; Kjell Någren; Jacques Darcourt; Klaus Tatsch; Koen J Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236

7.  Recurrent transient topographical amnesia: a patient with frequent episodes.

Authors:  Akihiro Shindo; Masayuki Satoh; Hiroyuki Kajikawa; Nobuo Ito; Haruna Miyamura; Hidekazu Tomimoto
Journal:  J Neurol       Date:  2011-03-10       Impact factor: 4.849

8.  Computer-assisted diagnostic system for neurodegenerative dementia using brain SPECT and 3D-SSP.

Authors:  Kazunari Ishii; Tomonori Kanda; Takafumi Uemura; Naokazu Miyamoto; Toshiki Yoshikawa; Kenichi Shimada; Shingo Ohkawa; Satoshi Minoshima
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-16       Impact factor: 9.236

9.  Cerebral blood volume in Alzheimer's disease and correlation with tissue structural integrity.

Authors:  Jinsoo Uh; Kelly Lewis-Amezcua; Kristin Martin-Cook; Yamei Cheng; Myron Weiner; Ramon Diaz-Arrastia; Michael Devous; Dinggang Shen; Hanzhang Lu
Journal:  Neurobiol Aging       Date:  2009-02-05       Impact factor: 4.673

10.  White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI.

Authors:  Yu Zhang; Norbert Schuff; An-Tao Du; Howard J Rosen; Joel H Kramer; Maria Luisa Gorno-Tempini; Bruce L Miller; Michael W Weiner
Journal:  Brain       Date:  2009-05-12       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.